期 |
栏目 |
标题 |
文件 |
卷 81, 编号 7 (2009) |
Editorial |
Results of the treatment of adult acute lymphoblastic leukemia according to ALL-2005 protocol as a basis for new trials |
|
卷 82, 编号 7 (2010) |
Editorial |
Toxicity of different treatment protocols for acute myeloid leukemias in adults: the results of four Russian multicenter studies |
|
卷 83, 编号 7 (2011) |
Editorial |
Pilot results of therapy of adult Ph-negative acute lymphoblastic leukemia according to the protocol of Research Group of Russian Hematological Centers ALL-2009 |
|
卷 84, 编号 7 (2012) |
Editorial |
The first results of treatment for adult acute myeloid leukemia according to the AML-01.10 protocol of the Research Group of the Hematology Centers of Russia |
|
卷 84, 编号 7 (2012) |
Editorial |
Primary lymphomas of bones and soft tissues: comparative assessment of treatment results |
|
卷 85, 编号 8 (2013) |
Editorial |
Efficiency of treatment of adult patients with acute T-lymphoblastic leukemia according to the ALL-2009 protocol of the Russian Acute Leukemia Study Group |
|
卷 87, 编号 7 (2015) |
Editorial |
Autologous hematopoietic stem cell transplantation as late high-dose consolidation in adult patients with T-cell lymphoblastic leukemias: Results of a Russian multicenter study |
|
卷 88, 编号 7 (2016) |
Editorial |
Acute Ph-negative lymphoblastic leukemias in adults: Risk factors in the use of the ALL-2009 protocol |
(Rus)
|
卷 89, 编号 7 (2017) |
Editorial |
Adult B-cell acute lymphoblastic leukemias: Conclusions of the Russian prospective multicenter study ALL-2009 |
(Rus)
|
卷 78, 编号 7 (2003) |
Editorial |
Computer multimedia case history as a present-day tool of keepingrecords |
|
卷 91, 编号 7 (2019) |
Editorial |
Risk - adapted intensive induction therapy, autologous stem cell transplantation, and rituximab maintenance allow to reach a high 7-year survival rate in patients with mantle cell lymphoma |
(Rus)
|